This article is more than 5 years old. Information may no longer be current.

Corin Group announces launch of reverse shoulder system in US market

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Corin Group announced the U.S. launch of the Humelock Reversed Shoulder System.

According to a company press release, the Humelock Reversed Shoulder System was developed by FX Solutions, a privately held French company, to treat cuff tear arthropathy. The Humelock Reversed Shoulder System is available in European and other international markets and received FDA clearance in January 2017. Corin holds a distribution agreement for the system, which grants the company the right to distribute the system in the United States (U.S.), the United Kingdom and Germany.

“Our partnership with FX Solutions allows Corin to increase their offering in shoulder arthroplasty, whilst we continue to expand solutions in hip and knee,” Paul Berman, president of Corin USA, said in the release. “Our goal is to provide surgeons, hospitals, health systems and patients with a new and comprehensive approach to orthopedics and joint replacement. The launch of the Humelock Reversed Shoulder System means patients in the U.S. will have access to an important new option for reverse shoulder replacement.”

Reference:

www.coringroup.com